APA (7th ed.) Citation

AI, F., S, R., MD, C., T, L., Jr, C. J., JR, B., & PJ, B. (2018). HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design. Cell host & microbe, 24(5), 703. https://doi.org/10.1016/j.chom.2018.10.009

Chicago Style (17th ed.) Citation

AI, Flyak, Ruiz S, Colbert MD, Luong T, Crowe JE Jr, Bailey JR, and Bjorkman PJ. "HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site That Can Be Targeted for Vaccine Design." Cell Host & Microbe 24, no. 5 (2018): 703. https://doi.org/10.1016/j.chom.2018.10.009.

MLA (9th ed.) Citation

AI, Flyak, et al. "HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site That Can Be Targeted for Vaccine Design." Cell Host & Microbe, vol. 24, no. 5, 2018, p. 703, https://doi.org/10.1016/j.chom.2018.10.009.